Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ELoomis
    Junior Member
    • Sep 2011
    • 9

    #1

    Hello from Davis, CA

    Hi all,
    My name is Erick Loomis and I'm a Genetics grad student at UC Davis. I'm a long time creeper and relatively new poster here. I'm a wet-lab molecular biologist by training, but I'm also a huge nerd for DNA sequence. I currently study the trinucleotide repeat expansion that causes Fragile X Syndrome, and that has limited the amount of sequencing I could do prior to the next-next-generation long-read sequencers. I've had a lot of success with the PacBio RS for long repetitive sequences, but I'm also a big fan in general of DNA sequence as a readout for molecular experiments. In my spare time, I like to clumsily install bioinformatics packages on my macbook by blindly using "configure, make, sudo make install". I'm comfortable and somewhat competent with the unix shell and perl, and somewhat less so, for now, python and R. I'm exceedingly grateful for the SEQanswers community and especially the patience of programmers in dealing with my questions about why the program they gave me for free doesn't do exactly the thing I want it to on the first try.

    Thanks,
    Erick

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Working...